|
Australia & New Zealand Pharmaceutical Research & Development News is an EIN News Service for pharmaceuticals professionals. Constantly updated news and information about Australia & New Zealand Pharmaceuticals.
Latest Australia & New Zealand Pharmaceutical Research & Development News
- Junk Science To A Public Health Danger? 7 Dec 2009 02:52 GMT
... Weekly use increased risk by 50 percent. Australian researchers have also found a link with ... profession can be this piece on Cancer Research UK's website. With an RR of 1.5 ... We receive no money or expenses from pharmaceutical or tobacco companies. 1. Read the news ...
- Pharma initiative saved money, lives 6 Dec 2009 14:54 GMT
... [it]." The Therapeutics Initiative is an independent research agency at the University of B.C. that ... B.C. that analyzes the effectiveness of the pharmaceutical industry's products. It's credited with saving hundreds ... that is not political or partisan." But drug companies have been trying for years to silence ...
- New Research Report: Consumer Electronics in the United States 6 Dec 2009 20:12 GMT
... Fast Market Research recommends "Consumer Electronics in the United States" ... Ukraine and the United Kingdom. Asia-Pacific comprises Australia, China, Japan, India, Singapore, South Korea and ... & Utilities, Financial Services, Logistics & Express, Pharmaceutical & Healthcare, Retail, Technology and Telecoms industries. ...
- Bioengineering the perfect athlete 6 Dec 2009 05:54 GMT
... conducted at the Garvan Institute of Medical Research in Sydney, Australia, found that athletes' performance ... Nine out of every 10 medicines that drug companies put into human testing fail, either because ... athletes. Wyeth, one of the world's largest pharmaceutical companies, created a myostatin-blocking drug and put ...
- Soliris Reduced Hemolysis, Decreased Transfusion Requirements and Improved Fatigue in Patients with PNH and Bone Marrow 6 Dec 2009 15:24 GMT
... Insufficiency Disorders a first-in-class terminal complement inhibitor developed by (Nasdaq: ALXN), reduced hemolysis (destruction of ... Ph.D., Executive Vice President and Head of Research and Development at Alexion. "The results presented ... for detection of new safety findings. Alexion Pharmaceuticals, Inc. is a biopharmaceutical company working to ...
- Soliris® Reduced Hemolysis, Decreased Transfusion Requirements and Improved Fatigue in Patients with PNH and Bone Marrow Insufficiency Disorders 6 Dec 2009 15:41 GMT
... a first-in-class terminal complement inhibitor developed by (Nasdaq: ALXN), reduced hemolysis (destruction of ... Ph.D., Executive Vice President and Head of Research and Development at Alexion. "The results presented ... for detection of new safety findings. Alexion Pharmaceuticals, Inc. is a biopharmaceutical company working to ...
- Soliris(R) Reduced Hemolysis, Decreased Transfusion Requirements and Improved Fatigue in Patients with PNH and Bone Marrow Insufficiency Disorders 6 Dec 2009 15:41 GMT
... Annual Meeting a first-in-class terminal complement inhibitor developed by ), reduced hemolysis (destruction of red ... Ph.D., Executive Vice President and Head of Research and Development at Alexion. "The results presented ... for detection of new safety findings. Alexion Pharmaceuticals, Inc. is a biopharmaceutical company working to ...
- p2pnet World Headlines: Dec 4, 2009 6 Dec 2009 04:32 GMT
... has been called into question by new research. Swiss iPhone developer Nicolas Seriot has published research on security ... report reviewed dozens of cases involving counterfeited pharmaceutical drugs, toothpaste, oil pipeline couplings, sports jerseys, ...
- Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcomi 6 Dec 2009 17:35 GMT
... presented at ASH will demonstrate the vigorous research underway to explore the best treatment approaches ... pipeline features compounds in all phases of development, including six in late-stage development, and encompasses ... meet these needs: innovative medicines, cost-saving generic pharmaceuticals, preventive vaccines, diagnostic tools and consumer health ...
- Recently released market study: Fruit & Vegetables in the United States 6 Dec 2009 20:16 GMT
... Recently published research from Datamonitor, "Fruit & Vegetables in the ... this report * Spot future trends and developments * Inform your business decisions * Add ... & Utilities, Financial Services, Logistics & Express, Pharmaceutical & Healthcare, Retail, Technology and Telecoms industries. ...
- New CML Drug Overcomes Resistance Mutation 6 Dec 2009 02:10 GMT
... Cancer Center. The investigational drug, omacetaxine, being developed by ChemGenex Pharmaceuticals Limited, based in Menlo Park, Calif., and ... disease becomes smaller," Larson said. Larson disclosed grant/research support from Amgen, Bristol-Myers Squibb, Celgene, Hana ...
- Is Money Tainting the Plasma Supply? 6 Dec 2009 13:25 GMT
... Yuma, Ariz. The centers are run by pharmaceutical companies that transform the plasma into life-saving ... says Dr. Jay Epstein, director of blood research at the Food and Drug Administration, which ... Baxter International of Deerfield, Ill.; CSL of Australia; Talecris, of Research Triangle Park, N.C.; Grifols ...
- Nplate(R) Data From MDS Studies Presented at ASH 6 Dec 2009 18:50 GMT
... use of Nplate and incidence of antibody development to Nplate and/or thrombopoietin (TPO). Secondary endpoints ... approved in the European Union (EU), Canada, Australia, Russia and the United States (U.S.). Nplate ... containment as well as U.S. legislation affecting pharmaceutical pricing and reimbursement. Government and others' regulations ...
- Newly published market report: Sports Equipment in the United States 6 Dec 2009 19:59 GMT
... Ukraine and the United Kingdom. Asia-Pacific comprises Australia, China, Japan, India, Singapore, South Korea and ... 1 Market Overview 1.1 Market Definition 1.2 Research Highlights 1.3 Market Analysis CHAPTER 2 Market ... & Utilities, Financial Services, Logistics & Express, Pharmaceutical & Healthcare, Retail, Technology and Telecoms industries. ...
- PharmAthene Presents Animal Model Data for Valortim(R) at the 2009 BARDA Industry Conference / PHEMCE Stakeholders Workshop / Data Show Valortim(R) is Efficacious in the New Zealand White Rabbit Model for Inhalation Anthrax at Ver 4 Dec 2009 19:11 GMT
... ANNAPOLIS, Md., Dec. 4 /PRNewswire-FirstCall/ -- PharmAthene, Inc. (NYSE Amex: PIP), a biodefense company developing medical countermeasures against biological and chemical threats, ... and by NIAID and the Biomedical Advanced Research and Development Authority (BARDA) under contract HHSN272200700033C. ...
Powered by 
Australia & New Zealand Pharmaceuticals News Sections
These stories are not published by IPD Group, Inc. and these links will take you to other websites. Some of these websites require their own registration to read their stories.
<<< Please read the disclaimer for more details.>>> | |
Pharmaceutical Industry Today
|
a digital news provider
>
Pharmaceutical Research & Development
ap.org:
cnn.com:
bbc.co.uk:
healthday.com: